# name
Esophageal involvement in DPP4 inhibitor-associated bullous pemphigoid

# metadata.dc.description.abstract[].value
Dipeptidyl-peptidase 4 inhibitors (DPP4i) are widely used hypoglycemic drugs strongly associated with bullous pemphigoid (BP), the most common autoimmune subepidermal blistering disease. DPP4i-associated BP may display differences in histological, immunological, and clinical features. Here we present the case of a patient treated with DPP4i who developed a severe BP involving both the skin and esophagus.

# metadata.dc.relation.ispartof[].value
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2023, vol. 22, num.3, p. 430-432

# metadata.dc.rights[].value
cc by-nc (c) Brufau Cochs, Magí, et al., 2023

# metadata.dc.source[].value
Articles publicats en revistes (Medicina)

# metadata.dc.title[].value
Esophageal involvement in DPP4 inhibitor-associated bullous pemphigoid